Literature DB >> 20013270

Non-Hodgkin's lymphoma following treatment with etanercept in ankylosing spondylitis.

Kenan Aksu1, Seckin Cagirgan, Nazan Ozsan, Gokhan Keser, Fahri Sahin.   

Abstract

Anti-TNF drugs may increase lymphoma risk in autoimmune rheumatic diseases, such as rheumatoid arthritis, but there have been no reports stating increased risk of lymphoma in ankylosing spondylitis (AS). Before 2 years, we had presented a case with AS developing Hodgkin's lymphoma following 6 months of etanercept treatment. Hereby, we present another case with AS developing non-Hodgkin's lymphoma (NHL), subsequent to 11 months of etanercept treatment. Pathological analysis revealed diffuse large B cell NHL. Although this is a report of a single case, cautious use of anti-TNF drugs is strongly recommended as they might cause lymphoma development even in AS.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20013270     DOI： 10.1007/s00296-009-1265-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  10 in total

1.  Autologous stem cell transplantation in a lymphoma patient with a long history of ankylosing spondylitis.

Authors:  E Jantunen; R Myllykangas-Luosujärvi; O Kaipiainen-Seppänen; T Nousiainen
Journal:  Rheumatology (Oxford)       Date:  2000-05       Impact factor: 7.580

Review 2.  Side effects of anti-TNF therapy: current knowledge.

Authors:  C Antoni; J Braun
Journal:  Clin Exp Rheumatol       Date:  2002 Nov-Dec       Impact factor: 4.473

3.  Primary synovial non-Hodgkin's lymphoma in association with ankylosing spondylitis.

Authors:  S Y Khan; D G Hutchinson
Journal:  Rheumatology (Oxford)       Date:  2004-03       Impact factor: 7.580

4.  Hodgkin's lymphoma following treatment with etanercept in ankylosing spondylitis.

Authors:  Kenan Aksu; Ayhan Donmez; Yesim Ertan; Gokhan Keser; Vedat Inal; Gonca Oder; Murat Tombuloglu; Yasemin Kabasakal; Eker Doganavsargil
Journal:  Rheumatol Int       Date:  2007-07-11       Impact factor: 2.631

5.  Risk of cancer in Turkish patients after treatment with TNF antagonists.

Authors:  S Pay
Journal:  Rheumatology (Oxford)       Date:  2008-02-23       Impact factor: 7.580

6.  Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study.

Authors:  J Askling; L Klareskog; P Blomqvist; M Fored; N Feltelius
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

7.  Leukemic phase of follicular lymphoma after treatment with etanercept in a patient with psoriasis.

Authors:  Siddhartha Ganguly
Journal:  Am J Clin Dermatol       Date:  2009       Impact factor: 7.403

8.  Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients.

Authors:  Frederick Wolfe; Kaleb Michaud
Journal:  Arthritis Rheum       Date:  2004-06

Review 9.  Malignancy and autoimmunity.

Authors:  Sasha Bernatsky; Rosalind Ramsey-Goldman; Ann Clarke
Journal:  Curr Opin Rheumatol       Date:  2006-03       Impact factor: 5.006

10.  Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis.

Authors:  Corey A Siegel; Sadie M Marden; Sarah M Persing; Robin J Larson; Bruce E Sands
Journal:  Clin Gastroenterol Hepatol       Date:  2009-01-24       Impact factor: 11.382
  10 in total
  5 in total

Review 1.  A dermatologist guide to immunogenicity.

Authors:  Collin M Blattner; Soham P Chaudhari; John Young; Jenny E Murase
Journal:  Int J Womens Dermatol       Date:  2016-07-18

2.  Sources of information on lymphoma associated with anti-tumour necrosis factor agents: comparison of published case reports and cases reported to the French pharmacovigilance system.

Authors:  Hélène Théophile; Thierry Schaeverbeke; Ghada Miremont-Salamé; Abdelilah Abouelfath; Valentine Kahn; Françoise Haramburu; Bernard Bégaud
Journal:  Drug Saf       Date:  2011-07-01       Impact factor: 5.606

Review 3.  Spinal non-Hodgkin's lymphoma mimicking a flare of disease in a patient with ankylosing spondylitis treated with anti-TNF agents: case report and review of the literature.

Authors:  Sara Monti; Nicola Boffini; Marco Lucioni; Marco Paulli; Carlomaurizio Montecucco; Roberto Caporali
Journal:  Clin Rheumatol       Date:  2014-04-05       Impact factor: 2.980

4.  Intestinal Peripheral T-Cell Lymphoma in a Patient with Ankylosing Spondylitis Under Treatment with Infliximab: A Case Report and Review of the Literature.

Authors:  Firdevs Ulutaş; Cansu Korkmaz; Halil Yılmaz; Duygu Akça; Erdem Çomut; Mustafa Çelık; Veli Çobankara
Journal:  Mediterr J Rheumatol       Date:  2022-06-30

Review 5.  Classifying the Linkage between Adipose Tissue Inflammation and Tumor Growth through Cancer-Associated Adipocytes.

Authors:  Yae Chan Song; Seung Eon Lee; Young Jin; Hyun Woo Park; Kyung-Hee Chun; Han-Woong Lee
Journal:  Mol Cells       Date:  2020-09-30       Impact factor: 5.034
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.